NICE feedback?The National Institute for Health and Care Excellence (NICE) is quite far along a NICE-led process to review Share XNICE feedback?https://pharmaphorum.com/views-and-analysis/nice-feedback/
How digital pathways are changing healthcareAs demonstrated throughout COVID, digital health is no longer experimental. Digital technologies are proving their value by allowing Share XHow digital pathways are changing healthcarehttps://pharmaphorum.com/digital/how-digital-pathways-are-changing-healthcare/
A life sciences vision to deliver health, wealth and resilience for the UKThe ABPI’s chief executive Dr Richard Torbett outlines a new ‘vision’ and 10-year strategy for UK life sciences, Share XA life sciences vision to deliver health, wealth and resilience for the UKhttps://pharmaphorum.com/views-and-analysis/a-life-sciences-vision-to-deliver-health-wealth-and-resilience-for-the-uk/
Deep Dive: Oncology 2021This has probably been the toughest year for oncology researchers in memory. As this issue’s contributors discuss, funding Share XDeep Dive: Oncology 2021https://pharmaphorum.com/views-analysis-oncology/deep-dive-oncology-2021/
Building honest dialogue with patient advocatesHow can the industry listen to patients in a way that puts the person behind the disease first? Share XBuilding honest dialogue with patient advocateshttps://deep-dive.pharmaphorum.com/magazine/market-access-2021/building-honest-dialogue-with-patient-advocates/
Turning words into actions with patient engagementBoehringer Ingelheim’s Carinne Brouillon tells us how the company co-created its recent Global Patient Partnership Summit with patients Share XTurning words into actions with patient engagementhttps://deep-dive.pharmaphorum.com/magazine/market-access-2021/turning-words-into-actions-with-patient-engagement-boehringer-ingelheim/
A roadmap for adopting New ScienceThe pandemic’s disruption galvanised the biopharma industry into unprecedented action, demonstrating what’s possible when the global scientific community Share XA roadmap for adopting New Sciencehttps://pharmaphorum.com/market-access-2/a-roadmap-for-adopting-new-science/
How the patient voice is becoming vital for drug approvalRebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a much-needed Share XHow the patient voice is becoming vital for drug approvalhttps://deep-dive.pharmaphorum.com/magazine/market-access-2021/patient-voice-drug-approvals-lipodystrophy/
What’s affordable anyway? The future of NHS drug spendingThe single biggest monetary difference that can be made to the successor to the UK’s 2019 Voluntary Scheme Share XWhat’s affordable anyway? The future of NHS drug spendinghttps://pharmaphorum.com/views-and-analysis/vpas-future-nhs-drug-spending/
